Skip to main content
. 2016 Aug 20;7(41):66660–66678. doi: 10.18632/oncotarget.11433

Figure 2. CHKA upregulation predicts poor prognosis in patients with CRC.

Figure 2

(A–B) Kaplan-Meier curves for disease-free survival (A) and disease-specific survival (B) of all CRC patients in the study cohort according to CHKA expression status. (C–D) Kaplan-Meier curves for disease-free survival (C) and disease-specific survival (D) of patients with early stage tumors according to CHKA expression status. (E–F) Kaplan-Meier curves for disease-free survival (E) and disease-specific survival (F) of patients with advanced stage tumors according to CHKA expression status. The p-value was determined using the log-rank test. The absolute number of patients at risk in each subgroup was listed below.